• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白激酶C在成人T细胞白血病细胞中的表达改变。

Altered expression of protein kinase C in adult T-cell leukemia cells.

作者信息

Hidaka M, Nakakuma H, Kawaguchi T, Nagakura S, Horikawa K, Okuno Y, Kagimoto T, Takatsuki K

机构信息

Second Department of Internal Medicine, Kumamoto University Medical School, Japan.

出版信息

Int J Hematol. 1992 Oct;56(2):135-41.

PMID:1421175
Abstract

Protein kinase C (PKC) has been shown to be involved in the mitogenic response and in oncogenic cell transformation in many experimental models. We analyzed the expression of PKC in both highly purified leukemic T cells freshly isolated from adult T-cell leukemia (ATL) patients and control T lymphocytes obtained from healthy volunteers. PKC activity was decreased in the ATL cells as compared with the control T cells. Cytosolic PKC activity in the ATL cells was remarkably decreased, whereas particulate membrane PKC activity was similar to the control level. The percentage of PKC activity in the particulate fraction was 34% in the ATL cells and 19% in the control cells. Regarding the altered subcellular localization of PKC activity, phorbol ester-induced translocation of cytosolic PKC was inhibited in some ATL cases. Similarly to the decrease in PKC activity, there was a decrease in the expression of the major PKC isozymes II(beta) and III(alpha) in ATL cells. These results suggest impaired regulation of PKC expression in ATL as well as in many experimental cancers.

摘要

蛋白激酶C(PKC)已被证明在许多实验模型中参与促有丝分裂反应和致癌细胞转化。我们分析了从成人T细胞白血病(ATL)患者新鲜分离的高度纯化白血病T细胞和从健康志愿者获得的对照T淋巴细胞中PKC的表达。与对照T细胞相比,ATL细胞中的PKC活性降低。ATL细胞中的胞质PKC活性显著降低,而颗粒膜PKC活性与对照水平相似。颗粒部分中PKC活性的百分比在ATL细胞中为34%,在对照细胞中为19%。关于PKC活性的亚细胞定位改变,在一些ATL病例中,佛波酯诱导的胞质PKC易位受到抑制。与PKC活性降低相似,ATL细胞中主要PKC同工酶II(β)和III(α)的表达也降低。这些结果表明,ATL以及许多实验性癌症中PKC表达的调节受损。

相似文献

1
Altered expression of protein kinase C in adult T-cell leukemia cells.蛋白激酶C在成人T细胞白血病细胞中的表达改变。
Int J Hematol. 1992 Oct;56(2):135-41.
2
Expression of three major protein kinase C isozymes in various types of human leukemic cells.三种主要蛋白激酶C同工酶在各类人白血病细胞中的表达
Cancer Res. 1991 Aug 15;51(16):4271-8.
3
Regulation of protein kinase C isoform proteins in phorbol ester-stimulated Jurkat T lymphoma cells.佛波酯刺激的Jurkat T淋巴瘤细胞中蛋白激酶C同工型蛋白的调控
J Immunol. 1993 Mar 1;150(5):1746-54.
4
Human T lymphocyte activation by tumor promoters: role of protein kinase C.肿瘤启动子对人T淋巴细胞的激活作用:蛋白激酶C的作用
J Immunol. 1987 May 15;138(10):3100-7.
5
Inhibition of phorbol ester-induced T cell proliferation by bryostatin is associated with rapid degradation of protein kinase C.苔藓抑素对佛波酯诱导的T细胞增殖的抑制作用与蛋白激酶C的快速降解有关。
J Immunol. 1993 Feb 15;150(4):1195-204.
6
Heterogeneity of protein kinase C isoenzyme gene expression in human T cell lines. Protein kinase C-beta is not required for several T cell functions.
J Immunol. 1989 Sep 1;143(5):1692-5.
7
Protein kinase C beta gene expression is associated with susceptibility of human promyelocytic leukemia cells to phorbol ester-induced differentiation.蛋白激酶Cβ基因表达与人早幼粒细胞白血病细胞对佛波酯诱导分化的敏感性相关。
Cell Growth Differ. 1992 Oct;3(10):739-45.
8
Properties of classic protein kinase C in human small cell lung carcinoma NCI-H345 cells.人小细胞肺癌NCI-H345细胞中经典蛋白激酶C的特性
Cell Growth Differ. 1995 Dec;6(12):1627-34.
9
Tumor necrosis factor signal transduction. Cell-type-specific activation and translocation of protein kinase C.肿瘤坏死因子信号转导。蛋白激酶C的细胞类型特异性激活与转位。
J Immunol. 1990 Apr 1;144(7):2604-8.
10
Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells.B2缓激肽受体在上皮性乳腺细胞中的促有丝分裂信号传导
J Cell Physiol. 2004 Oct;201(1):84-96. doi: 10.1002/jcp.20052.

引用本文的文献

1
Phase I dose-escalation study to determine the safety, tolerability, preliminary efficacy and pharmacokinetics of an intratumoral injection of tigilanol tiglate (EBC-46).一项评估 EBC-46(替拉诺他)瘤内注射的安全性、耐受性、初步疗效和药代动力学的 I 期剂量递增研究。
EBioMedicine. 2019 Dec;50:433-441. doi: 10.1016/j.ebiom.2019.11.037. Epub 2019 Dec 3.
2
The protein kinase C agonist PEP005 (ingenol 3-angelate) in the treatment of human cancer: a balance between efficacy and toxicity.蛋白激酶 C 激动剂 PEP005(ingenol 3-angelate)治疗人类癌症:疗效与毒性之间的平衡。
Toxins (Basel). 2010 Jan;2(1):174-94. doi: 10.3390/toxins2010174. Epub 2010 Jan 22.
3
Human T-cell lymphotropic virus type 1 Tax1 activation of NF-kappa B: involvement of the protein kinase C pathway.
人类嗜T细胞病毒1型Tax1激活核因子κB:蛋白激酶C途径的参与
J Virol. 1996 Apr;70(4):2525-32. doi: 10.1128/JVI.70.4.2525-2532.1996.